A gene therapy targeting medium-chain acyl-CoA dehydrogenase (MCAD) did not protect against diabetes-induced cardiac pathology

Weeks, KL; Kiriazis, H; Wadley, Glenn; Masterman, EI; Sergienko, NM; Raaijmakers, AJA; Trewin, AJ; Harmawan, CA; Yildiz, GS; Liu, Y; Drew, BG; Gregorevic, P; Delbridge, LMD; McMullen, JR; Bernardo, BC

A gene therapy targeting medium-chain acyl-CoA dehydrogenase (MCAD) did not protect against diabetes-induced cardiac pathology

Version 2 2024-06-03, 02:03

Version 1 2023-12-04, 04:48

journal contribution

posted on 2024-06-03, 02:03 authored by KL Weeks, H Kiriazis, Glenn WadleyGlenn Wadley, EI Masterman, NM Sergienko, AJA Raaijmakers, AJ Trewin, CA Harmawan, GS Yildiz, Y Liu, BG Drew, P Gregorevic, LMD Delbridge, JR McMullen, BC Bernardo

A gene therapy targeting medium-chain acyl-CoA dehydrogenase (MCAD) did not protect against diabetes-induced cardiac pathology

History

Journal

Journal of Molecular Medicine

Pagination

1-17

Location

Berlin, Germany

Publisher DOI

https://doi.org/10.1007/s00109-023-02397-2

ISSN

0946-2716

eISSN

1432-1440

Language

eng

Author URL

https://www.ncbi.nlm.nih.gov/pubmed/37987775

Publication classification

C1 Refereed article in a scholarly journal

Publisher

Springer

Publication URL

http://dx.doi.org/10.1007/s00109-023-02397-2

Usage metrics

Keywords

Dehydrogenase Diabetes Diabetic cardiomyopathy Gene therapy Metabolism

Licence

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

A gene therapy targeting medium-chain acyl-CoA dehydrogenase (MCAD) did not protect against diabetes-induced cardiac pathology

History

Journal

Pagination

Location

Publisher DOI

ISSN

eISSN

Language

Author URL

Publication classification

Publisher

Publication URL

Usage metrics

Categories

Keywords

Licence

Exports